Cargando…

Health Anxiety and Its Relationship to Thyroid-Hormone-Suppression Therapy in Patients with Differentiated Thyroid Cancer

SIMPLE SUMMARY: Differentiated thyroid cancer (DTC) has a good prognosis; however, patients often need lifelong follow up and face potentially chronic psychiatric problems, such as health anxiety. We investigated the relationship between health anxiety and TSH-suppression treatment, which many patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zoltek, Maximilian, Andersson, Therese M.-L., Axelsson, Erland, Hedman, Christel, Ihre Lundgren, Catharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140054/ https://www.ncbi.nlm.nih.gov/pubmed/35625954 http://dx.doi.org/10.3390/cancers14102349

Ejemplares similares

Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer
por: Nilsson, Joachim N., et al.
Publicado: (2023)

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index
por: Nilsson, Joachim N., et al.
Publicado: (2021)

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
por: Nilsson, Joachim N, et al.
Publicado: (2023)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
por: Johansson, Klara, et al.
Publicado: (2021)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

Minimally invasive follicular thyroid carcinomas: prognostic factors
por: Stenson, Gustav, et al.
Publicado: (2016)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

Cost effectiveness of internet-based cognitive behaviour therapy and behavioural stress management for severe health anxiety
por: Hedman, Erik, et al.
Publicado: (2016)

Quality of Life in Patients with Benign Non-toxic Goiter after Surgical Intervention: A Systematic Review and Meta-Analysis
por: Ihre-Lundgren, Catharina
Publicado: (2022)

Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
por: Wang, Ruihua, et al.
Publicado: (2018)

Joint factor analysis and approximate equipercentile linking of common trait health anxiety measures: a cross-sectional study of the 14-, 18- and 64-item health anxiety inventory, the illness attitude scale, and the 14-item Whiteley Index
por: Axelsson, Erland, et al.
Publicado: (2023)

The 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 Administered Via the Internet to Individuals With Anxiety and Stress Disorders: A Psychometric Investigation Based on Data From Two Clinical Trials
por: Axelsson, Erland, et al.
Publicado: (2017)

Recurrence of Differentiated Thyroid Carcinoma During Full TSH Suppression: Is the Tumor Now Thyroid Hormone Dependent?
por: Davis, Paul J., et al.
Publicado: (2014)

Roxadustat and thyroid-stimulating hormone suppression
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021)

The Relationships between Thyroid Hormones and Thyroid-stimulating Hormone with Lipid Profile in Euthyroid Men
por: Chin, Kok-Yong, et al.
Publicado: (2014)

The Effect of ThyroidߚStimulating Hormone on Stage of Differentiated Thyroid Carcinoma
por: Soleimanisardoo, Laya, et al.
Publicado: (2021)

Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis
por: Yoon, Byung-Ho, et al.
Publicado: (2019)

Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study
por: Jin, Shan, et al.
Publicado: (2019)

Actions of Thyroid Hormones on Thyroid Cancers
por: Mousa, Shaker A., et al.
Publicado: (2021)

Dityrosine suppresses the cytoprotective action of thyroid hormone T3 via inhibiting thyroid hormone receptor-mediated transcriptional activation
por: Ding, Yin-Yi, et al.
Publicado: (2020)

The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors
por: Eriksson, John, et al.
Publicado: (2016)

Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer
por: Lee, Youjin, et al.
Publicado: (2019)

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
por: Wolfson, Robert M., et al.
Publicado: (2016)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

Thyroid Hormone Response Element Half-Site Organization and Its Effect on Thyroid Hormone Mediated Transcription
por: Paquette, Martin A., et al.
Publicado: (2014)

Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression
por: Sohn, Seo Young, et al.
Publicado: (2015)

Correction: Thyroid Hormone Response Element Half-Site Organization and Its Effect on Thyroid Hormone Mediated Transcription
Publicado: (2014)

Relationship Between Thyroid-Stimulating Hormone Level and Aggressive Pathological Features of Papillary Thyroid Cancer
por: Demircioglu, Zeynep Gul, et al.
Publicado: (2022)

Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels
por: Babić Leko, Mirjana, et al.
Publicado: (2021)

Effect of Thyroid-Stimulating Hormone Suppression on Muscle Function After Total Thyroidectomy in Patients With Thyroid Cancer
por: Lee, Jun Choul, et al.
Publicado: (2021)

The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway
por: Yu, Zhen-xing, et al.
Publicado: (2022)

Regulation of Inhibitors of Differentiation Family Proteins by Thyroid-Stimulating Hormone in FRTL-5 Thyroid Cells
por: Jo, Young Suk, et al.
Publicado: (2008)

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?
por: Hasbek, Zekiye, et al.
Publicado: (2016)

Transiently impaired endothelial function during thyroid hormone withdrawal in differentiated thyroid cancer patients
por: Hou, Li-ying, et al.
Publicado: (2023)

Thyroid Hormone Metabolism
por: Alexander, Nicholas M.
Publicado: (1976)

Thyroid Hormones and Mesotherapy
por: Marrif, Husnia I.
Publicado: (2011)

The Thyroid Hormones and Their Action
Publicado: (1952)

Bisphenols and Thyroid Hormone
por: Kim, Min Joo, et al.
Publicado: (2019)

Identification of a Thyroid Hormone Binding Site in Hsp90 with Implications for Its Interaction with Thyroid Hormone Receptor Beta
por: Fan, Lu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4l98ojqp86m3asu8kmda0gjm3m